Literature DB >> 17133419

Acquired von Willebrand syndrome: an update.

Massimo Franchini1, Giuseppe Lippi.   

Abstract

Acquired von Willebrand syndrome (aVWS) is a rare bleeding disorder with laboratory findings similar to those for congenital von Willebrand disease (VWD). However, unlike congenital VWD, it arises in individuals with no personal or family history of bleeding. aVWS occurs in association with a variety of underlying disorders, most frequently in lymphoproliferative disorders, myeloproliferative disorders, and cardiovascular diseases. Through an analysis of the more recent literature data, the pathophysiology and the clinical, laboratory, and therapeutic aspects of this syndrome are concisely reported in this review. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17133419     DOI: 10.1002/ajh.20830

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  24 in total

1.  Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.

Authors:  Stefania Vaglio; Domenico Prisco; Gianni Biancofiore; Daniela Rafanelli; Paola Antonioli; Michele Lisanti; Lorenzo Andreani; Leonardo Basso; Claudio Velati; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2015-12-15       Impact factor: 3.443

Review 2.  Laboratory testing for von Willebrand disease: toward a mechanism-based classification.

Authors:  Richard Torres; Yuri Fedoriw
Journal:  Clin Lab Med       Date:  2009-06       Impact factor: 1.935

3.  Monoclonal gammopathy of undetermined significance: significant beyond hematology.

Authors:  Steven Vanderschueren; Marieke Mylle; Daan Dierickx; Michel Delforge; Peter Verhamme; Kathelijne Peerlinck; Wouter Meersseman; Daniël C Knockaert
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

4.  Acquired von Willebrand syndrome: von Willebrand factor propeptide to von Willebrand factor antigen ratio predicts remission status.

Authors:  Adrienne Lee; Gary Sinclair; Karen Valentine; Paula James; Man-Chiu Poon
Journal:  Blood       Date:  2014-06-20       Impact factor: 22.113

Review 5.  [Management of bleeding disorders in intensive care medicine].

Authors:  S Petros
Journal:  Med Klin Intensivmed Notfmed       Date:  2011-10-23       Impact factor: 0.840

Review 6.  Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: case report and review of literature.

Authors:  Jameel Muzaffar; Lakshmikanth Katragadda; Sajjad Haider; Ali Javed; Elias Anaissie; Saad Usmani
Journal:  Int J Hematol       Date:  2011-12-15       Impact factor: 2.490

7.  Spontaneous iris bleeding during cataract surgery in a patient with thrombocytopenia.

Authors:  Karen L Christopher; Ksenia Stafeeva; Michael S Erlanger
Journal:  Digit J Ophthalmol       Date:  2015-09-18

8.  Bleeding from gastrointestinal angioectasias is not related to bleeding disorders - a case control study.

Authors:  Charlotte M Höög; Olle Broström; Tomas L Lindahl; Andreas Hillarp; Gerd Lärfars; Urban Sjöqvist
Journal:  BMC Gastroenterol       Date:  2010-09-28       Impact factor: 3.067

9.  Von Willebrand disease: an overview.

Authors:  K Pavani Bharati; U Ram Prashanth
Journal:  Indian J Pharm Sci       Date:  2011-01       Impact factor: 0.975

10.  A case of essential mixed cryoglobulinemia and associated acquired von-Willebrand disease treated with rituximab.

Authors:  Semir Pasa; Abdullah Altintas; Timucin Cil; Ramazan Danis; Orhan Ayyildiz; Ekrem Muftuoglu
Journal:  J Thromb Thrombolysis       Date:  2008-01-13       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.